Dr Yue-Teh Jang

KANDO id: 27449

Bio

Yue-Teh Jang, Ph.D. has over twenty years of experience in various executive positions in the health care industry. He was President and Chief Executive Officer of Embol-X, a private company engaged in the development of proprietary medical devices to prevent stroke during cardiac surgery and other interventional procedures. Prior to that time, Dr. Jang was a vice-president for corporate R&D at Boston Scientific, vice-president for R&D at Cardiovascular Imaging Systems, a project manager with Mallinckrodt Medical, and a scientist with Deseret Medical. He currently serves on the Boards of Directors of Dynamic Implants, Forte Bio Inc. and Inphenix Corp. He previously served on the Boards of Directors of Intergrated Vascular Systems Inc. and Ensure Medical. Dr. Jang received a B.S. in Materials Science from National Tsing-Hua University, Taiwan and a Ph.D. in Materials Science from the University of Utah.

Education